Trust Company’s Protolabs PRLB Stock Holding History

Trust Company’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-70	Closed	-$2.5K	–	347
2024 Q1	$2.5K	Buy	+70	New	+$2.53K	﹤0.01%	319

Other funds holding PRLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Trust Company's PRLB Position: Q2 2024 in Review

Trust Company sold out of Protolabs (PRLB) in Q2 2024, closing a stake of 70 shares — an estimated $2.5K sold.

Trust Company first reported a position in PRLB in Q1 2024 and held it in 1 quarter. The position peaked at $2.5K in Q1 2024. 204 funds tracked by Wall St. Rank hold PRLB as of Q2 2024.

Trust Company reported no remaining Protolabs position as of Q2 2024 after selling out during the quarter.
Trust Company sold 70 Protolabs shares in Q2 2024, an estimated $2.5K.
Trust Company first reported a position in Protolabs in Q1 2024 and held it in 1 quarter.
Trust Company's Protolabs position peaked at $2.5K in Q1 2024.
204 funds tracked by Wall St. Rank held Protolabs as of Q2 2024.

Based on Trust Company's 13F filing for Q2 2024, filed 15 Jul 2024.